Overview
Portfolio
More
Bioventuresinvestors
Boston, United States
Invests in cutting‑edge biomedical technologies to improve health outcomes and reduce care costs.
Portfolio
8+
Employees
10+
Founded
2000
AUM
≈ $150.0M
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Fund details
Funds
Growth Capital Fund
$25.0M
Innovation Fund
$10.0M
BioVentures Investors Limited Partnership II
BioVentures Investors Fund
$87.0M
Sources
Bioventuresinvestors
Invests in cutting‑edge biomedical technologies to improve health outcomes and reduce care costs.
Portfolio
8+
Employees
10+
Founded
2000
AUM
≈ $150.0M
Funds
Growth Capital Fund · $25.0M
Innovation Fund · $10.0M
BioVentures Investors Limited Partnership II
BioVentures Investors Fund · $87.0M
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Showing 4 of 4 matched portfolio companies
BRAINBox Solutions™ utilizes blood biomarker panels and tablet-based neurocognitive testing to provide objective evidence of mild traumatic brain injury (mTBI) and predict post-injury symptom outcomes. This multi-modality approach enhances diagnostic accuracy and informs clinicians about the likelihood of recovery, addressing the need for improved assessment in traumatic brain injury cases.
Funding: $23.0M
Rough estimate of the amount of funding raised
Funding: $23.0M
Rough estimate of the amount of funding raised
CareSignal provides real-time patient monitoring through standardized SMS text messages and IVR phone calls, enabling healthcare providers to collect patient-reported outcomes and prioritize outreach to at-risk individuals. This technology leads to measurable improvements, including a 59% reduction in heart failure emergency department visits and a 75% engagement rate among members over six months.
CoNextions Medical develops the CoNextions TR® Tendon Repair System and Coronet® Soft Tissue Fixation System, which utilize pioneering implants for strong and secure soft tissue-to-bone fixation without the need for sutures. These technologies address the high complication rates and inefficiencies associated with traditional tendon repair methods, offering repairs that are two times stronger and 3.1 times faster than conventional suturing techniques.
Funding: $2.3M
Rough estimate of the amount of funding raised
Funding: $2.3M
Rough estimate of the amount of funding raised
SonoMotion is developing a non-invasive medical device platform that utilizes low-pressure ultrasound waves to fragment and reposition kidney stones in awake patients, eliminating the need for general anesthesia and x-ray radiation. This approach addresses the high volume of kidney stone procedures by providing a safer, cost-effective treatment option that can be performed in an office setting.
Funding: $12.4M
Rough estimate of the amount of funding raised
Funding: $12.4M
Rough estimate of the amount of funding raised
Showing 4 of 4 unmatched portfolio companies